Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Bronchial epithelial transcriptome reveals dysregulated interferon and inflammatory responses to rhinovirus in exacerbation-prone pediatric asthma
Naresh Doni Jayavelu, Basilin Benson, Patricia C. dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, Camile R. Gates, Andrew J. Nagel, Maria P. White, Nyssa B. Samanas, Kourtnie Whitfield, Teal S. Hallstrand, Steven F. Ziegler, Matthew C. Altman, Jason S. Debley
Naresh Doni Jayavelu, Basilin Benson, Patricia C. dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, Camile R. Gates, Andrew J. Nagel, Maria P. White, Nyssa B. Samanas, Kourtnie Whitfield, Teal S. Hallstrand, Steven F. Ziegler, Matthew C. Altman, Jason S. Debley
View: Text | PDF
Research Article Cell biology Immunology Pulmonology

Bronchial epithelial transcriptome reveals dysregulated interferon and inflammatory responses to rhinovirus in exacerbation-prone pediatric asthma

  • Text
  • PDF
Abstract

Host factors influencing susceptibility to rhinovirus-induced asthma exacerbations remain poorly characterized. Using organotypic bronchial epithelial cultures from well-characterized children with asthma and healthy children, this study investigated viral load kinetics and resultant host responses by bulk and single-cell transcriptomics and targeted protein analyses. Bronchial epithelium from exacerbation-prone children exhibited greater rhinovirus replication and a cascade of exaggerated downstream interferon (IFN), inflammatory, epithelial stress, and remodeling responses. These transcriptional patterns were confirmed and further refined using single-cell transcriptomics, revealing cell type–specific contributions — particularly from non-ciliated cell populations including secretory immune response, tuft, and basal cells. We observed that these post-infection differences were associated with lower pre-infection IFN-stimulated gene (ISG) expression and protein levels of the ISG CXCL10. Prophylactic IFN-β treatment reduced viral replication and normalized downstream responses, supporting low baseline (pre-infection) IFN tone as a modifiable causal determinant of host susceptibility to adverse rhinovirus-induced responses in exacerbation-prone children with asthma.

Authors

Naresh Doni Jayavelu, Basilin Benson, Patricia C. dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, Camile R. Gates, Andrew J. Nagel, Maria P. White, Nyssa B. Samanas, Kourtnie Whitfield, Teal S. Hallstrand, Steven F. Ziegler, Matthew C. Altman, Jason S. Debley

×

Figure 3

Prophylactic IFN-β treatment reduces RV replication and ameliorates epithelial IFN, inflammatory, and remodeling pathways.

Options: View larger image (or click on image) Download as PowerPoint
Prophylactic IFN-β treatment reduces RV replication and ameliorates epit...
(A) Dot plot showing log-transformed viral copy number values by exacerbation status between samples at day 2 treated with IFN-β. The IFN-β–treated group showed a significant decrease in viral load compared with the untreated samples in both exacerbation groups with a 3.39-fold decrease in the NSE group (n = 6 donors) and a 4.22-fold decrease in the SE group (n = 6 donors); bars indicate mean and interquartile range for each group. (B) Dot plot showing expression changes in the Interferon Response module by IFN-β treatment. Regression plot showing association between the Interferon Response module and viral load by IFN-β treatment. (C) Dot plot showing expression changes in the Epithelial Remodeling and Inflammation module by IFN-β treatment. Regression plot showing association between the Epithelial Remodeling and Inflammation module and viral load by IFN-β treatment. (D) Dot plot showing expression changes in the Stress Response module by IFN-β treatment. Regression plot showing association between the Stress Response module and viral load by IFN-β treatment. (E) Dot plot showing expression changes in the Cellular Metabolism module by IFN-β treatment. Regression plot showing association between the Cellular Metabolism module and viral load by IFN-β treatment. (F) Dot plot showing expression changes in the Cellular Transcriptional Activity module by IFN-β treatment. Regression plot showing association between the Cellular Transcriptional Activity module and viral load by IFN-β treatment. Bars indicate median and interquartile range for each group, and the fit line is based on a linear model including 95% CIs.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts